Related Experiment Videos
Increased interleukin-6 activity in cardiac myxoma with mediastinal lymphadenopathy
Internal Medicine (Tokyo, Japan)
|October 1, 1992
Insights
A rare cardiac myxoma case presented with mediastinal lymphadenopathy. Interleukin-6 (IL-6) levels decreased, and lymphadenopathy resolved after tumor removal, suggesting IL-6
Area of Science:
- Cardiology
- Oncology
- Immunology
Background:
- Cardiac myxomas are rare primary heart tumors.
- Mediastinal lymphadenopathy is an uncommon presentation of cardiac myxoma.
Observation:
- A patient presented with cardiac myxoma and concurrent mediastinal lymphadenopathy.
- Elevated serum interleukin-6 (IL-6) activity was detected.
Findings:
- Surgical resection of the cardiac myxoma led to the resolution of mediastinal lymphadenopathy.
- Post-operative serum IL-6 levels significantly decreased.
Implications:
- This case suggests a potential role for IL-6 in the development of lymphadenopathy associated with cardiac myxoma.
- IL-6 may be a key mediator linking cardiac myxoma to systemic inflammatory manifestations.
Abstract:
We report a case of cardiac myxoma with mediastinal lymphadenopathy which seems to be a very rare feature. Laboratory examination revealed high level of interleukin-6 (IL-6) activity in serum. Interestingly, after removal of cardiac myxoma, mediastinal lymphadenopathy disappeared on the chest CT and the level of serum IL-6 was decreased. These findings suggest that IL-6 which was probably derived from myxoma, may have played an important role in the development of lymphadenopathy.